At Everest Regenerative Medicine, we view tirzepatide not as a stand-alone fat loss injection, but as one powerful component of a personalized, regenerative planone where we evaluate your metabolism, hormones, lifestyle, and then integrate this advanced therapy when appropriate
Retatrutide: Phase-2 trial Retatrutide is an investigational triple agonist (GLP-1, GIP and glucagon receptors), adding a third hormone target to potentially boost metabolism further
Usage could be temporary or cyclical The typical duration of GLP-1 medication intake is six to 12 months, and fewer than half (48.2%) of current weight-loss users have been on the drug for an entire year
Some advantages, for this group include
Balancing Benefits with Safety Like all powerful therapies, retatrutide comes with considerations that patients and clinicians must weigh carefully